Reaktion #1507238
ord-a5083eee7e054e4eae431502dc6b8fda
Reaktionsgleichung
5,10-dihydro-4H-pyrazolo[5,1-c][1,4]benzodiazepine
4-[(5-fluoro-2-methylbenzoyl)amino]-2-chlorobenzoyl chloride
diisopropylethylamine
→
N-[4-(4H-Pyrazolo[5,1-c][1,4]benzodiazepin-5(10H)-ylcarbonyl)-3-chlorophenyl]-5-fluoro-2-methylbenzamide
Edukte
Reagenzien
Keine
Lösungsmittel
Reaktionsbedingungen
Detaillierte Bedingungen
See reaction.notes.procedure_details.
Aufarbeitung
- 1WaschenThe mixture is washed with H2O, 1N HCl, H2O, 1M NaHCO3, brine
- 2Trocknendried (Na2SO4)
- 3Waschenthe filter cake washed with dichloromethane
- 4EinengenThe filtrate is concentrated
- 5Sonstigethe solid crystallized from ethyl acetate
- 6Sonstigeto give crystals, m.p. 137°-140° C.
Vorschrift
A mixture of 0.185 g of 5,10-dihydro-4H-pyrazolo[5,1-c][1,4]benzodiazepine, 0.391 g of 4-[(5-fluoro-2-methylbenzoyl)amino]-2-chlorobenzoyl chloride and 0.158 g of diisopropylethylamine in 10 ml of dichloromethane is stirred at room temperature overnight. The mixture is washed with H2O, 1N HCl, H2O, 1M NaHCO3, brine and dried (Na2SO4). The solution is passed through a thin pad of hydrous magnesium silicate and the filter cake washed with dichloromethane. The filtrate is again passed through a thin pad of hydrous magnesium silicate. The filtrate is concentrated and the solid crystallized from ethyl acetate to give crystals, m.p. 137°-140° C.